Abstract
Xylosyl adenine (XA) was found to prolong the survival time of mice bearing TA3 or Ehrlich ascites cell tumors. Experiments with either TA3 or Ehrlich cells demonstrated that XA markedly inhibited the incorporation of 14C-labeled adenine or glycine into both RNA and DNA.
XA was relatively rapidly converted in vivo and in vitro to the triphosphate (XATP).
XA was as effective as adenosine as a feedback inhibitor of purine synthesis.
XATP was found to be profoundly inhibitory to the formation of 5-phosphoribosyl-1-pyrophosphate (PRPP). This effect on the PRPP supply appeared to be the most likely explanation for the inhibitory effects on RNA and DNA synthesis, and for the inhibition of cell growth.
ACKNOWLEDGMENT This work was supported by Contract No. PH-43-65-575 with the Cancer Chemotherapy National Service Center, National Cancer Institute, National Institutes of Health.
- Copyright ©, 1965, by Academic Press Inc.
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
